Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引：66
作者：
Larkin, Howard D. D.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 05期
关键词：
D O I：
10.1001/jama.2022.24490
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
[11]   TREATMENT FOR IMPOTENCE GAINS FDA APPROVAL [J].
不详 .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (19) :2078-2079
[12]   GE salmon gains FDA approval [J].
Cima, Greg .
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 248 (01) :25-25
[13]   Leptin therapy gains FDA approval [J].
Gunjan Sinha .
Nature Biotechnology, 2014, 32 :300-301
[14]   Integrase inhibitor gains FDA approval [J].
Traynor, Kate .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (22) :2310-2310
[15]   Sugar substitute gains FDA approval [J].
不详 .
FOOD AUSTRALIA, 1998, 50 (06) :262-262
[16]   Leptin therapy gains FDA approval [J].
Sinha, Gunjan .
NATURE BIOTECHNOLOGY, 2014, 32 (04) :300-302
[17]   Alzheimer?s disease: FDA approves lecanemab amid cost and safety concerns [J].
Mahase, Elisabeth .
BMJ-BRITISH MEDICAL JOURNAL, 2023, 380 :p73
[18]   Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care Incremental Step or Paradigm Shift? [J].
Knopman, David S. ;
Hershey, Linda .
NEUROLOGY, 2023, 101 (14) :610-620
[19]   Catheter gains US FDA approval for treating peripheral vascular disease [J].
不详 .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (08) :1054-1054
[20]   Lecanemab, a Novel Amyloid ß-Directed Antibody for Early Alzheimer Disease [J].
Toderika, Yuliana ;
Najib, Jadwiga .
JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (09)
12345